Key Highlights: ARCHER Phase II Trial Design and Topline Results Cardiol Therapeutics’ ARCHER trial was a multi-national, randomized, double-blind, placebo-controlled Phase II study evaluating…
- CFTC targets spot crypto trading and tokenized collateral rules by year-end - SEC delays crypto projects as shutdown halts staff work on policy…
- Robinhood adds BNB trading as the token's market cap nears $150 billion - BNB rises from $500 to $1,350 in 2025 driven by…
Prices for gold and silver experienced their biggest one-day declines in years on Oct. 21 as the rally in precious metals came to an…
Hong Kong's Securities and Futures Commission (SFC) has approved the territory's first Solana (CRYPTO: $SOL) spot exchange-traded fund (ETF). The new ETF will track…
With U.S. markets hanging on every Federal Reserve signal, Fed Governor Christopher Waller has delivered a message investors can’t ignore: monetary policy will not…
After months of speculative fervor, gold and silver markets just delivered a wake-up call. Gold prices saw their sharpest one-day drop in five years,…
Must Read
